Bio-Path Holdings, Inc.盘中异动股价大涨5.61%报1.13美元

市场透视10-23

北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价大幅拉升5.61%。截至发稿，该股报1.13美元/股，成交量12.9224万股，换手率3.48%，振幅6.54%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.87百万美元，每股收益-1.16美元，毛利-32000.00美元，市盈率-0.08倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477136160?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-23 02:27","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477136160","market":"us","top_or_hot":-1,"title":"Bio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价大幅拉升5.61%。截至发稿，该股报1.13美元/股，成交量12.9224万股，换手率3.48%，振幅6.54%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.87百万美元，每股收益-1.16美元，毛利-32000.00美元，市盈率-0.08倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-23 02:27 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价大幅拉升5.61%。截至发稿，该股报1.13美元/股，成交量12.9224万股，换手率3.48%，振幅6.54%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.87百万美元，每股收益-1.16美元，毛利-32000.00美元，市盈率-0.08倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BPTH","symbol_name":"Bio-Path Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","article_id":"2477136160","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023022748ab6c4805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477136160","pubTimestamp":1729621668,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.股票出现异动，股价大幅拉升5.61%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为5525.90%、4986.46%、2140.56%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BPTH":"Bio-Path Holdings, Inc.","BK4139":"生物科技"},"translate_title":"Bio-Path Holdings, Inc. shares jumped 5.61% to $1.13 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPTH":1},"content_text":"北京时间2024年10月23日02时27分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价大幅拉升5.61%。截至发稿，该股报1.13美元/股，成交量12.9224万股，换手率3.48%，振幅6.54%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.87百万美元，每股收益-1.16美元，毛利-32000.00美元，市盈率-0.08倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm (Holdings) Plc较为活跃，换手率分别为5525.90%、4986.46%、2140.56%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。 它致力于利用一项新技术，用以实现对疾病中过度表达的任何基因产物的靶标特异性蛋白质抑制的系统递送。 该公司的候选药物 prexigebersen 正处于与低剂量阿糖胞苷（LDAC）联合治疗以及与地西他滨联合治疗急性髓性白血病（AML）的 2 期临床试验的疗效部分。 该公司的其他药物有BP1002、BP1003、BP1001-A和DNABILIZE。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477136160"}

Bio-Path Holdings, Inc.盘中异动 股价大涨5.61%报1.13美元

精彩评论

Bio-Path Holdings, Inc.盘中异动股价大涨5.61%报1.13美元